ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J07BC01 | B | Hepatitis B, surface antigen - 10mcg/0.5ml | 10584 | 118820/1 | ENGERIX-B 10 | 10mcg/0.5ml | 0.5ml | Injectable suspension | IM | Abela Frères S.A.L. | GlaxoSmithKline Biologicals SA | Belgium | 1,042,822 L.L | 23.08 | A2 | GlaxoSmithKline Biologicals SA | Belgium | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J07BC01 | G | Hepatitis B, purified surface antigen adsorbed on aluminium hydroxide (Al+++) (0.25mg to 0.40mg) - 10mcg/0.5ml | 8453 | 167618/10 | HEPATITIS-B VACCINE (r DNA) PAEDIATRIC | 10mcg/0.5ml | 1 | Injectable suspension | IM | Unipharm S.A.L. | Serum Institute of India Ltd | India | 323,866 L.L | 23.08 | A1 | Serum Institute of India Ltd | India | 2/5/2024 | 0 |